Jiangsu (SH:688426) Xin Lang Cai Jing·2025-10-23 03:35Group 1 - The core point of the news is that Jiangsu Kangwei Century Biotechnology Co., Ltd. has seen a stock price increase of 5.5%, reaching 28.79 yuan per share, with a total market capitalization of 3.239 billion yuan [1] - The company specializes in the research, production, and sales of molecular detection products, with 89.14% of its revenue coming from product sales and 10.86% from services [1] - The company was established on September 3, 2010, and was listed on October 25, 2022 [1] Group 2 - According to data, the fund "Shenwan Lixin Medical Pioneer Stock A" holds a significant position in Kangwei Century, having reduced its holdings by 12,000 shares in the second quarter, now holding 445,600 shares, which constitutes 7.43% of the fund's net value [2] - The fund has experienced a loss of 7% this year, ranking 4215 out of 4218 in its category, and a loss of 10.41% over the past year, ranking 3867 out of 3875 [2] - The fund manager, Yao Hongfu, has been in charge for 3 years and 98 days, with the best and worst fund returns during his tenure being -31.23% and -32.27%, respectively [3]